Albion Capital

Albion Venture Capital (AAVC) Update 4, 14 Oct 2019

AAVC Chairman Richard Glover invited ShareSoc to a meeting to discuss our concerns as part of his process to engage with Shareholders, following the 30% vote against the new management agreement voted on at the EGM in August 2019 and the very extensive questioning at the AGM (see the AGM write up by Tim Gratton https://www.sharesoc.org/agm-reports/d4t4-solutions-d4t4-agm-report-2/  and my own report https://www.sharesoc.org/blog/vcts/albion-venture-capital-vct-aavc-agm-result-and-actions/ . AAVC is engaging with a broad range of shareholders and has written to about 50% of the larger shareholders who ...

Albion Venture Capital VCT Blog number 2

Albion want to change the performance fee from the current arrangement (1.9% management fee, plus 8% of returns over a hurdle rate of 5% per annum with a high-water mark) to 20% of returns above a hurdle of RPI +2%p.a., from a new starting point of NAV at 1 April 2019. ShareSoc recommends shareholders vote against this proposal and other resolutions at the AGM on 21 August. 1.9% plus 20% is egregious, particularly when: it represents an increase from historically agreed arrangements and  ...

VCTs – Possible budget changes and pre-planning our response

The autumn statement/budget on 22nd November is getting closer, so we may soon learn the government's views on patient capital. At a Proven VCT meeting on 1 November the VCT manager, Stuart Veale, seemed certain that something will change for VCTs, but nobody knows what. Richard Waltham spoke to him afterwards to suggest that if the changes are adverse then the main focus for lobbying could move from the Treasury to MPs. It may only take a handful of MPs to trigger ...